Related Experiment Video
Updated: Jun 23, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
Abstract:
Danazol, approved 5 years ago for the treatment of pelvic endometriosis, has recently been approved for treating cystic disease of the breast. As the mechanisms of action of this drug are made clear, the clinical syndromes that can be treated by this impeded androgen have increased dramatically. Results of controlled prospective clinical studies on the drug have increased our understanding of the pathophysiology of several poorly understood diseases. Danazol is well tolerated by most patients; the side effects are mild and reversible.
Insights
Danazol, an androgen medication, is now approved for endometriosis and cystic breast disease. Its clarified mechanisms of action expand treatment possibilities for various conditions, with generally mild and reversible side effects.
Area of Science:
- Pharmacology
- Gynecology
- Endocrinology
Background:
- Danazol, initially approved for pelvic endometriosis, has expanded therapeutic applications.
- Recent approval for cystic breast disease highlights evolving clinical use.
- Understanding Danazol's mechanisms of action is crucial for its expanded indications.
Purpose of the Study:
- To review the expanded clinical applications of Danazol.
- To discuss the pharmacological mechanisms underlying Danazol's efficacy.
- To summarize findings from prospective clinical studies on Danazol's use.
Main Methods:
- Review of controlled prospective clinical studies.
- Analysis of pharmacological data on Danazol's mechanism of action.
- Clinical assessment of patient tolerance and side effect profiles.
Main Results:
- Danazol's efficacy is demonstrated in treating pelvic endometriosis and cystic breast disease.
- Mechanisms of action clarify its utility in diverse clinical syndromes.
- Prospective studies enhance understanding of related disease pathophysiology.
- Danazol is generally well-tolerated with mild, reversible side effects.
Conclusions:
- Danazol is a valuable therapeutic agent with expanding clinical utility.
- Further research into its mechanisms of action will likely reveal additional applications.
- Danazol offers a favorable safety profile for managing specific gynecological and breast conditions.
Related Concept Videos
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Antihypertensive Drugs: Thiazide-Class Diuretics
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Antiprotozoal Agents

![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)